设为首页         

资讯内容 Content

[ACC2010]对II型糖尿病患者而言,血压控制在减少心血管死亡和全因死亡方面的作用--William C. Cushman教授专访
国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

国际循环 时间:2010/3/16 16:40:00热点聚焦(专题) 高血压试验  关键字:II型糖尿病 血压控制 

<International Circulation>:

Can you compare and contrast the differences between ACCORD and ADVANCE?
 

<Prof Cushman>: 

ADVANCE gave two very good medicines: a thiazide diuretic and an ACE inhibitor compared to placebo, on top of other therapies in diabetics. ADVANCE was a bigger population since they put their entire 10000+ people on drug or placebo for blood pressure. ADVANCE was not a blood pressure goal study, so they had no goal at all. They ended up with a mean blood pressure in the intensively treated group of 135mmHg. That is right at or right above what our standard group was, so I do consider ADVANCE a positive study as they did get a 14% reduction in mortality even though the macro-vascular outcomes were not significantly reduced, but overall it was a positive study. To me, it says that our standard group and their intensively treated group which were very similar in blood pressure level, is a good level to be at in diabetics.



上一页  [1]  [2]  [3]  [4]  [5]  下一页

查看更多评论>>

相关视频

 
关于本站 | 设为首页 | 加入收藏 | 站长邮箱 | 友情链接 | 版权申明

声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。

国际循环 版权所有  2008-2024 icirculation.com  All Rights Reserved